REG - Haleon PLC - Transaction in Own Shares

HALEONAnnouncement

16/04/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250416:nRSP1812Fa&default-theme=true

RNS Number : 1812F  Haleon PLC  16 April 2025

 

Haleon plc: Transaction in own shares

 

16 April 2025: Haleon plc (the "Company" or "Haleon") today announces the
purchase of the following number of ordinary shares of £0.01 each in the
Company (the "Shares") for cancellation under its share buyback programme
announced on 28 March 2025 (the "Buyback Programme").

 

 Date of purchase:                                  15 April 2025
 Number of Shares purchased:                        855,279
 Highest price paid per Share (p):                  381.20
 Lowest price paid per Share (p):                   377.10
 Volume weighted average price paid per Share (p):  379.18

 

Following the settlement of the above, the Company's registered share capital
is 9,028,701,792 ordinary shares of £0.01 each, of which 4,080,205 are held
as treasury shares. Therefore, the number of ordinary shares with voting
rights is 9,024,621,587 and this figure may be used by shareholders to
determine if they are required to notify their interest, or a change to their
interest, in Haleon under the FCA's Disclosure Guidance and Transparency
Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it
applies in the UK (the Market Abuse Regulation), a full breakdown of the
individual trades is available at the link below:

 

http://www.rns-pdf.londonstockexchange.com/rns/1812F_1-2025-4-15.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/1812F_1-2025-4-15.pdf)

 

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

 

This announcement and individual trade breakdown will also be available on the
Company's website at: www.haleon.com/investors
(http://www.haleon.com/investors) .

 

 Enquiries

 Investors                                                                       Media

 Jo Russell                              +44 7787 392441                         Zoë Bird                             +44 7736 746167
 Rakesh Patel                            +44 7552 484646                         Victoria Durman                      +44 7894 505730
 Emma White                              +44 7823 523562
 Email: investor-relations@haleon.com (mailto:investor-relations@haleon.com)     Email: corporate.media@haleon.com (mailto:corporate.media@haleon.com)

 

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose
to deliver better everyday health with humanity. Haleon's product portfolio
spans five major categories - Oral Health, Pain Relief, Respiratory Health,
Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu,
Otrivin, Polident, parodontax and Centrum - are built on trusted science,
innovation and deep human understanding.

 

For more information, please visit www.haleon.com (http://www.haleon.com/)
.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSDELFFEZLXBBK